Glucotrack (GCTK) Net Income towards Common Stockholders (2016 - 2020)
Historic Net Income towards Common Stockholders for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$878000.0.
- Glucotrack's Net Income towards Common Stockholders fell 11370.63% to -$878000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.1 million, marking a year-over-year decrease of 18890.26%. This contributed to the annual value of $8.0 million for FY2023, which is N/A changed from last year.
- Per Glucotrack's latest filing, its Net Income towards Common Stockholders stood at -$878000.0 for Q4 2020, which was down 11370.63% from -$887000.0 recorded in Q3 2020.
- In the past 5 years, Glucotrack's Net Income towards Common Stockholders ranged from a high of $18.5 million in Q4 2017 and a low of -$2.7 million during Q2 2017
- Its 5-year average for Net Income towards Common Stockholders is $376542.3, with a median of -$995951.0 in 2018.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 149760.6% in 2017, then tumbled by 15523.07% in 2019.
- Over the past 5 years, Glucotrack's Net Income towards Common Stockholders (Quarter) stood at -$1.3 million in 2016, then skyrocketed by 1497.61% to $18.5 million in 2017, then tumbled by 105.48% to -$1.0 million in 2018, then skyrocketed by 733.34% to $6.4 million in 2019, then plummeted by 113.71% to -$878000.0 in 2020.
- Its Net Income towards Common Stockholders was -$878000.0 in Q4 2020, compared to -$887000.0 in Q3 2020 and -$611000.0 in Q2 2020.